The correlation between gut microbiota and sleep quality changes in breast cancer patients receiving postoperative chemotherapy: a longitudinal study.
OpenAlex 토픽 ·
Gut microbiota and health
Cancer survivorship and care
Neutropenia and Cancer Infections
[STUDY OBJECTIVES] Sleep problems are common in breast cancer patients undergoing postoperative chemotherapy.
- 연구 설계 cross-sectional
APA
Mengru Wu, Fengxia Lai, et al. (2026). The correlation between gut microbiota and sleep quality changes in breast cancer patients receiving postoperative chemotherapy: a longitudinal study.. Journal of psychosomatic research, 205, 112617. https://doi.org/10.1016/j.jpsychores.2026.112617
MLA
Mengru Wu, et al.. "The correlation between gut microbiota and sleep quality changes in breast cancer patients receiving postoperative chemotherapy: a longitudinal study.." Journal of psychosomatic research, vol. 205, 2026, pp. 112617.
PMID
41785683
Abstract
[STUDY OBJECTIVES] Sleep problems are common in breast cancer patients undergoing postoperative chemotherapy. The association between gut microbiota dysbiosis and impaired sleep quality has been demonstrated in some cross-sectional studies. However, their longitudinal and temporal associations remain unclear.
[METHODS] A longitudinal study was conducted among breast cancer patients undergoing postoperative chemotherapy in two East China hospitals. Data collection included the general information form, the General Sleep Disturbance Scale, and fecal samples for 16S rRNA sequencing analysis. Repeated measures ANOVA examined sleep quality trajectories, growth mixture models (GMM) identified latent trajectory classes, and logistic regression explored class predictors. Cross-lagged panel models examined the temporal association between gut microbiota and sleep quality.
[RESULTS] Sleep quality initially declined and subsequently improved during chemotherapy, remaining lower than pre-chemotherapy levels. Distinct sleep trajectory classes were identified: persistent sleep disorder (23.81%), post-chemotherapy sleep disorder (45.24%), no sleep disorder (30.95%). Age, exercise frequency, mental stress, probiotic product consumption and chemotherapy regimen were significant predictors of trajectory class membership. Cross-lagged analyses indicated a lower Shannon index can affect a subsequent sleep quality decline. Faecalibacterium and Butyricicoccus abundance predicted improved subsequent sleep quality, while Intestinibacter abundance negatively predicted it. Ruminococcus demonstrated bidirectional temporal associations with sleep quality.
[CONCLUSION] Specific butyrate-producing gut bacteria, rather than overall microbial diversity, showed temporal associations with sleep quality in breast cancer patients undergoing chemotherapy. These findings suggest that targeted microbiota interventions warrant further investigation as potential strategies for improving sleep quality during cancer treatment.
[METHODS] A longitudinal study was conducted among breast cancer patients undergoing postoperative chemotherapy in two East China hospitals. Data collection included the general information form, the General Sleep Disturbance Scale, and fecal samples for 16S rRNA sequencing analysis. Repeated measures ANOVA examined sleep quality trajectories, growth mixture models (GMM) identified latent trajectory classes, and logistic regression explored class predictors. Cross-lagged panel models examined the temporal association between gut microbiota and sleep quality.
[RESULTS] Sleep quality initially declined and subsequently improved during chemotherapy, remaining lower than pre-chemotherapy levels. Distinct sleep trajectory classes were identified: persistent sleep disorder (23.81%), post-chemotherapy sleep disorder (45.24%), no sleep disorder (30.95%). Age, exercise frequency, mental stress, probiotic product consumption and chemotherapy regimen were significant predictors of trajectory class membership. Cross-lagged analyses indicated a lower Shannon index can affect a subsequent sleep quality decline. Faecalibacterium and Butyricicoccus abundance predicted improved subsequent sleep quality, while Intestinibacter abundance negatively predicted it. Ruminococcus demonstrated bidirectional temporal associations with sleep quality.
[CONCLUSION] Specific butyrate-producing gut bacteria, rather than overall microbial diversity, showed temporal associations with sleep quality in breast cancer patients undergoing chemotherapy. These findings suggest that targeted microbiota interventions warrant further investigation as potential strategies for improving sleep quality during cancer treatment.
MeSH Terms
Humans; Breast Neoplasms; Female; Gastrointestinal Microbiome; Longitudinal Studies; Middle Aged; Sleep Quality; Adult; Sleep Wake Disorders; China; Dysbiosis; Aged
같은 제1저자의 인용 많은 논문 (5)
- Key role of the autonomic nervous system in breast cancer (Review).
- Exploring the applicability, combined strategies, and challenges of ablation in hematology based on its characteristics and immunomodulatory mechanisms.
- Ferrocene-Modified Nanoscale Covalent Organic Frameworks for Ferroptosis-Based Sonodynamic Therapy Inhibit Breast Cancer and Its Bone Metastasis.
- Analysis of the mechanism and prognostic value of PRKCQ-AS1 in inhibiting the progression of lung adenocarcinoma via regulating the PD-1/PD-L1 pathway.
- How the gut microbiome affects the immunotherapy response in hepatocellular carcinoma.